Association of serum apoA-I with in-stent restenosis in coronary heart disease

Association of serum apoA-I with in-stent restenosis in coronary heart disease

Abstract Background Despite use of drug-eluting stents (DES), in-stent restenosis (ISR) continues adversely affecting clinical outcomes of patients undergoing percutaneous coronary intervention (PCI). Apolipoprotein A-I (apoA-I) has athero-protective effects. However, there is a paucity of clinical...

Full description

Bibliographic Details
Main Authors: Xin Wang, Min Zhang, Jie Cheng, Hua Zhou
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Cardiovascular Disorders
Subjects:
In-stent restenosis
apoA-I
Drug-eluting stents
Prediction
Online Access:https://doi.org/10.1186/s12872-022-02762-y

Internet

https://doi.org/10.1186/s12872-022-02762-y

Similar Items